Clinically Relevant Post-Translational Modification Analyses-Maturing Workflows and Bioinformatics Tools.
Dana PascoviciJemma X WuMatthew J McKayChitra JosephZainab NoorKarthik KamathYunqi WuShoba RanganathanVivek GuptaMehdi MirzaeiPublished in: International journal of molecular sciences (2018)
Post-translational modifications (PTMs) can occur soon after translation or at any stage in the lifecycle of a given protein, and they may help regulate protein folding, stability, cellular localisation, activity, or the interactions proteins have with other proteins or biomolecular species. PTMs are crucial to our functional understanding of biology, and new quantitative mass spectrometry (MS) and bioinformatics workflows are maturing both in labelled multiplexed and label-free techniques, offering increasing coverage and new opportunities to study human health and disease. Techniques such as Data Independent Acquisition (DIA) are emerging as promising approaches due to their re-mining capability. Many bioinformatics tools have been developed to support the analysis of PTMs by mass spectrometry, from prediction and identifying PTM site assignment, open searches enabling better mining of unassigned mass spectra-many of which likely harbour PTMs-through to understanding PTM associations and interactions. The remaining challenge lies in extracting functional information from clinically relevant PTM studies. This review focuses on canvassing the options and progress of PTM analysis for large quantitative studies, from choosing the platform, through to data analysis, with an emphasis on clinically relevant samples such as plasma and other body fluids, and well-established tools and options for data interpretation.
Keyphrases
- mass spectrometry
- data analysis
- human health
- label free
- high resolution
- liquid chromatography
- risk assessment
- capillary electrophoresis
- electronic health record
- gas chromatography
- high performance liquid chromatography
- climate change
- case control
- big data
- protein protein
- multiple sclerosis
- amino acid
- single molecule
- minimally invasive
- binding protein
- single cell
- small molecule
- density functional theory
- molecular dynamics
- genetic diversity
- deep learning
- affordable care act